辽宁医学杂志2024,Vol.38Issue(4) :26-28.

沙库巴曲缬沙坦与抗心衰联合治疗对HFrEF患者心功能分级、6min步行试验及心脏射血分数的影响

Effect of Sakubatril Valsartan in Combination with Standard Heart Failure Therapy on Cardiac Function Classification,6-min Walking Test and Left Ventricular Ejection Fraction in Patients with HFrEF

宋戈 何兆辉 韩慧想
辽宁医学杂志2024,Vol.38Issue(4) :26-28.

沙库巴曲缬沙坦与抗心衰联合治疗对HFrEF患者心功能分级、6min步行试验及心脏射血分数的影响

Effect of Sakubatril Valsartan in Combination with Standard Heart Failure Therapy on Cardiac Function Classification,6-min Walking Test and Left Ventricular Ejection Fraction in Patients with HFrEF

宋戈 1何兆辉 1韩慧想1
扫码查看

作者信息

  • 1. 河南大学第一附属医院(河南开封 475000)
  • 折叠

摘要

目的 分析沙库巴曲缬沙坦与抗心衰联合治疗对射血分数降低心力衰竭(HFrEF)患者心功能分级、6min步行试验及心脏射血分数(LVEF)的影响.方法 选择2019年12月至2021年10月诊治的HFrEF患者82例,采用计算机随机数分组法将全部患者分成标准组和联合组,例数均41例.标准组患者使用抗心衰药物治疗.联合组患者使用沙库巴曲缬沙坦与抗心衰联合治疗.对比分析两组患者心功能分级、6min步行试验及LVEF、心肌损伤指标水平.结果 治疗结束1d,2组患者心功能分级差异比较有统计学意义(P<0.05).治疗前1d,2组患者6min步行试验距离及LVEF值差异比较无统计学意义(P>0.05).治疗结束1d,联合组患者6min步行试验距离及LVEF值高于标准组(P<0.05).治疗前1d,2组患者NT-proBNP、Ⅰ cTnⅠ水平差异比较无统计学意义(P>0.05).治疗结束1d,联合组患者NT-proBNP、Ⅰ cTnⅠ水平低于标准组(P<0.05).结论 沙库巴曲缬沙坦与抗心衰联合治疗对HFrEF能明显患者心功能分级,增加6min步行试验距离及心脏射血分数,建议使用.

Abstract

Objective To analyze the effect of sakubatril valsartan in combination with standard heart failure therapy on cardiac function classification,6-min walking test and left ventricular ejection fraction(LVEF)in patients with heart failure with reduced ejection fraction(HFrEF).Methods Eighty-two patients with HFrEF in our hospital from December 2019 to 0ctober 2021 were enrolled,and randomly classified into two groups by computer,each with 41 cases.Standard group re-ceived standard heart failure therapy,while combined group received sakubatril valsartan in combination with standard heart failure therapy.Then the cardiac function classification,6-min walking test,LVEF and myocardial injury markers were com-pared between two groups.Results The cardiac function classification at post-treatment 1 d yielded statistical difference between two groups(P<0.05).The 6-min walking distance and LVEF value at the baseline demonstrated no statistical difference between groups(P>0.05),while the two values at post-treatment 1 d of combined group were remarkably higher in combined group than in standard group(P<0.05).Serum N-terminal prohormone of brain natriuretic peptide(NTproB-NP)and cardiac troponin Ⅰ(cTnⅠ)levels at baseline denoted no significant difference between groups(P>0.05),while the levels of two serum indicators were obviously lower in combined group than in standard group at post-treatment 1 d(P<0.05).Conclusion Application of sakubatril valsartan in combination with standard heart failure therapy in the treatment of HFrEF can effectively improve the cardiac function,improve the 6-min walking distance and LVEF value in patients,which is worthy of recommendation.

关键词

沙库巴曲缬沙坦/抗心衰/HFrEF/心功能分级/6min步行试验/心脏射血分数

Key words

Sacubitril Valsartan/Standard heart failure therapy/HFrEF/Cardiac function classification/The 6-min walking test/Left ventricular ejection fraction

引用本文复制引用

出版年

2024
辽宁医学杂志
辽宁省医学会

辽宁医学杂志

影响因子:0.339
ISSN:1001-1722
段落导航相关论文